Page last updated: 2024-10-29

ketoconazole and Splenic Diseases

ketoconazole has been researched along with Splenic Diseases in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Splenic Diseases: Diseases involving the SPLEEN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacDonald, HJ1
Fong, IW1
Gardiner, GW1
Soutter, DI1
Wali, JP1
Aggarwal, P1
Gupta, U1
Saluja, S1
Singh, S1

Other Studies

2 other studies available for ketoconazole and Splenic Diseases

ArticleYear
Splenic abscess caused by Blastomyces dermatitidis in association with peritoneal involvement: case report and review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:1

    Topics: Abscess; Ascites; Blastomycosis; Humans; Ketoconazole; Male; Middle Aged; Peritoneal Diseases; Splen

1992
Ketoconazole in treatment of visceral leishmaniasis.
    Lancet (London, England), 1990, Sep-29, Volume: 336, Issue:8718

    Topics: Adolescent; Adult; Drug Administration Schedule; Female; Humans; Ketoconazole; Leishmaniasis, Viscer

1990